Filter Results :

Your search for antibod returned 142 reports

Sort by


Antibody Target, Technology & Pipeline Database

30 Apr 2016  |  Published by:  La Merie Business Intelligence
Antibody Target, Technology & Pipeline Database: 1-Year Subscription Therapeutic monoclonal antibodies have become a clinically and commercially successful class of drugs. Branded therapeutic antibodies on the market reached global sales of US$ 91.5 bln in the year 2015, with a growth rate ...

$ 1,596.17

Read More

Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021 - Nanoparticles, Polymers, Liposomes, Micelles, Nanoemulsions, Dendrimers, Monoclonal Antibodies by Geography, Therapeutic Area and Stakeholder Environment

04 Apr 2016  |  Published by:  Kelly Scientific Publications
Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021 Nanoparticles, Polymers, Liposomes, Micelles, Nanoemulsions, Dendrimers, Monoclonal Antibodies by Geography, Therapeutic Area and Stakeholder Environment This newly published report is a global industry ...

$ 4,332.46

Read More

Global Antibody Conjugates Drugs Market 2016-2020

31 Mar 2016  |  Published by:  Technavio
About Antibody Drug Conjugates ADCs, empowered monoclonal antibodies (mAbs), use chemical linkers with labile bonds to attach biologically active substances. ADCs target mAbs with the cancer killing ability of cytotoxic drugs, allowing sensitive discernment between healthy and diseased tiss...

$ 2,500.00

Read More

Global Anti-CD20 Monoclonal Antibodies Industry 2016 Market Research Report

18 Mar 2016  |  Published by:  9Dimen Research
2016 Global Anti-CD20 Monoclonal Antibodies Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Anti-CD20 Monoclonal Antibodies industry, focusing on the main regions (North America, Europe and Asia) and the main count...

$ 2,850.00

Read More

Blockbuster Biologics 2015: Sales of Recombinant Therapeutic Antibodies & Proteins

01 Mar 2016  |  Published by:  La Merie Business Intelligence
This report prepared by La Merie Publishing provides a compilation of the sales data of originator recombinant therapeutic proteins and antibodies in the calendar year 2015. Sales data were obtained from company publications and refer to branded products originating from companies based in reg...

$ 136.81

Read More

Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

01 Mar 2016  |  Published by:  CurrentPartnering
The Global Cancer Monoclonal Antibody Partnering 2010-2016: Deal trends, players, financials and forecasts report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies. -Trends in cancer...

$ 1,995.00

Read More

Global Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

01 Mar 2016  |  Published by:  CurrentPartnering
The Global Monoclonal antibody Partnering Terms and Agreements 2010 to 2016: Deal trends, players, financials and forecasts report provides a detailed understanding and analysis of how and why companies enter monoclonal antibody partnering deals. The majority of deals are development stage whe...

$ 2,995.00

Read More

Global Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

01 Mar 2016  |  Published by:  CurrentPartnering
The Global Antibody Partnering Terms and Agreements 2010 to 2016 report provides comprehensive understanding and unprecedented access to the Antibody partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and ana...

$ 2,995.00

Read More

Competitor Analysis: Dengue Virus Vaccines, Antibodies & Antivirals

01 Feb 2016  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report provides a competitor evaluation in the field of approved and investigational vaccines and therapeutics against one or more serotypes of Dengue Virus for prophylaxis or treatment of Dengue fever as of February 2016. The report covers live attenuated or whol...

$ 228.02

Read More

Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016

10 Jan 2016  |  Published by:  DelveInsight
DelveInsight’s, “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016 report provides the information across the ADCs drug value chain. The Report is focused on the marketed and pipeline scenario of the ADCs. The Report has covered the 184 A...

$ 2,950.00

Read More

Engineered Bispecific Antibodies (BsAb) Novel Approaches & Pipeline Insights, 2016

01 Jan 2016  |  Published by:  DelveInsight
Summary “Engineered Bispecific Antibodies (BsAb) Novel Approaches & Pipeline Insights, 2016” emphasizes on the novel bispecific antibodies technologies in research and development. The report enlists company, target antigens, phase and indication specific R&D pipelines of Bispecifc ...

$ 2,750.00

Read More

Anti GM-CSF Antibody -Pipeline Insights, 2016

01 Jan 2016  |  Published by:  DelveInsight
Summary Anti GM-CSF Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti GM-CSF Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licen...

$ 1,250.00

Read More

Anti-CD105 Antibody -Pipeline Insights, 2016

01 Jan 2016  |  Published by:  DelveInsight
Summary Anti-CD105 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD105 Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensi...

$ 1,250.00

Read More

Anti-CD152 Antibody -Pipeline Insights, 2016

01 Jan 2016  |  Published by:  DelveInsight
Summary Anti-CD152 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD152 Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensi...

$ 1,250.00

Read More

Anti-CD19 Antibody -Pipeline Insights, 2016

01 Jan 2016  |  Published by:  DelveInsight
Summary Anti-CD19 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD19 Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing...

$ 1,250.00

Read More
Total 142 records.